M Marquet

High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation.

M. Marquet, R Lahijani, G Hulley, 1996, Human gene therapy.

Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.

M. Marquet, G. Budahazi, N A Horn, 1995, Human gene therapy.